Health IT Analytics July 24, 2020
Jessica Kent

The state-of-the-art laboratory will use artificial intelligence algorithms to conduct molecular testing and accelerate precision medicine.

Hackensack Meridian Health (HMH) and Genomic Testing Cooperative (GTC) are launching a next generation sequencing reference laboratory that will use artificial intelligence to advance precision medicine.

The state-of-the-art laboratory will be located at JFK Medical Center in Edison, New Jersey, and will initially focus on cancer before expanding to immune diseases and various chronic conditions. The lab will bring genomics to the active screening and prevention program at HMH.

“Investing in genomics and establishing a reference laboratory in genomics represents a new phase for Hackensack Meridian Health and demonstrates our commitment to be a leader in improving patient care,” noted Robert C. Garrett, FACHE,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Technology
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article